Literature DB >> 25804825

Restrictive myocardium with an unusual pattern of apical hypertrophic cardiomyopathy.

Takuma Sato1, Taka-Aki Matsuyama2, Osamu Seguchi3, Yoshihiro Murata3, Haruki Sunami3, Masanobu Yanase3, Tomoyuki Fujita4, Hatsue Ishibashi-Ueda2, Takeshi Nakatani3.   

Abstract

Loeffler endocarditis is a fibrous restrictive cardiomyopathy thought to be caused by persistent eosinophilia. It is difficult to diagnose, and the prognosis is often poor if the underlying eosinophilia is not promptly recognized and treated. We describe the case of a middle-aged woman treated for hypertrophic cardiomyopathy first detected during a routine check-up at age 35years but whose symptoms gradually progressed over the next 14years. Right ventricular biopsy showed extensive fibrosis of the endocardial tissue, and right heart catheterization revealed right heart failure and a low cardiac output state. Ultimately, she became reliant on inotropic and mechanical cardiovascular support, but we were not able to bridge her to transplant. Autopsy findings were typical of endocardial fibroelastosis, but she had not suffered from any tropical disease or traveled to high-risk areas. The presence of abnormal capillary proliferation suggested a diagnosis of Loeffler endocarditis. Nonetheless, apart from a 6-month period of eosinophilia 7years before her death, a history of well-controlled asthma and several drug sensitivities, we were unable to definitively identify the disease trigger. It is critical to diagnose and treat the underlying eosinophilia of Loeffler endocarditis to avoid a poor prognosis. This case highlights the importance of considering the diagnosis of eosinophilic endomyocarditis in patients with an unusual pattern of apical hypertrophic cardiomyopathy (or myocardial fibrosis of unknown etiology), even when there is no apparent history of eosinophilia.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiomyopathy; Eosinophilia; Heart failure; Hypereosinophilic syndrome; Hypertrophic; Restrictive

Mesh:

Year:  2015        PMID: 25804825     DOI: 10.1016/j.carpath.2015.03.001

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  1 in total

1.  Loeffler endocarditis in chronic eosinophilic leukemia with FIP1L1/PDGFRA rearrangement: full recovery with low dose imatinib.

Authors:  Dae Sik Kim; Sunki Lee; Chul Won Choi
Journal:  Korean J Intern Med       Date:  2017-06-28       Impact factor: 2.884

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.